DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...
The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...
A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...
Learn how to use ChatGPT with four practical prompts to identify, validate, market, and grow a side hustle with a realistic ...
Probius to develop AI-powered point-of-care screening technology, eliminating sample preparation requirements and ...
As building codes evolve and fire risks grow more complex, rigorous testing and third-party certification of passive fire ...
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Machine learning for health data science, fuelled by proliferation of data and reduced computational costs, has garnered ...
Third-party funded testwork on high-grade refractory gold systems positions RCL for regional deployment and licensing across Western North America ...
Accreditation reflects the company’s adherence to the highest standards of laboratory quality, stewardship, and ...
Predicting how circulating immune cells interact with human tissues remains a major challenge in preclinical drug testing.
Quickparts introduces DuraKor and ThermaKor materials with vapor smoothing to bridge prototyping and production manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results